Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)

Palestine · Delayed Price · Currency is JOD · Price in USD

3.740

0.00 (0.00%)

At close: Jul 5, 2026

87.00% (1Y)

Market Cap	94.41M +94.4%
Revenue (ttm)	35.57M +19.8%
Net Income	7.24M +48.9%
EPS	0.20 +30.2%
Shares Out	36.00M
PE Ratio	13.04
Forward PE	n/a
Dividend	0.05 (2.01%)
Ex-Dividend Date	Apr 16, 2026

Volume	4
Open	3.740
Previous Close	n/a
Day's Range	3.740 - 3.740
52-Week Range	1.900 - 4.000
Beta	0.43
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 6, 2026

About Jerusalem Pharmaceuticals

Jerusalem Pharmaceuticals Co. Ltd., together with its subsidiaries, manufactures and sells a range of human medicines and medical supplies in Palestine, the Middle East, North Africa, and internationally. It operates through two segments: Pharmaceutical Sales and All Other Segments. The company offers over the counter, prescription pharmaceutical, and nutritional supplement products in various dosage forms, including tablets, capsules, sterile injectables, powders for suspensions, suspensions, syrups, powders, suppositories, ovules, creams, and... [Read more]

Industry Pharmaceutical Preparations

Founded 1969

Employees 595

Stock Exchange Palestine Stock Exchange

Ticker Symbol JPH

Full Company Profile

Financial Performance

In 2025, Jerusalem Pharmaceuticals's revenue was $48.95 million, an increase of 22.91% compared to the previous year's $39.82 million. Earnings were $10.18 million, an increase of 102.13%.

Financial numbers in USD Financial Statements